SCHEMBL4676045

SCHEMBL4676045

O=C(c1ccco1)C(CC1CCNCC1)C1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
AGTR1 P30556 1/20 0.40
KMT2A Q03164 1/20 0.40
GBA1 P04062 1/20 0.39
CHRNB2 P17787 4/20 0.38
CHRNA7 P36544 4/20 0.38
CHRNA4 P43681 4/20 0.38
CHRNB4 P30926 3/20 0.38
CHRNA3 P32297 3/20 0.38
CPN1 P15169 2/20 0.37
CPB2 Q96IY4 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673078 0.74 CES2 (0.42) GBA1CPN1CPB2CES2CES1
SCHEMBL4676042 0.74 CHRNA7 (0.40) MEN1POLBAGTR1KMT2ACHRNB2
SCHEMBL4670637 0.74 CES2 (0.39) MEN1POLBKMT2ACPN1CPB2
SCHEMBL4672734 0.73 CPN1 (0.39) CPN1CPB2
SCHEMBL4674068 0.72 SLC6A2 (0.40) MEN1KMT2ACHRNB2CHRNA4CHRNB4
SCHEMBL12482406 0.68 HPGD (0.47) MEN1POLBAGTR1KMT2AALDH1A1
SCHEMBL12482402 0.68 HPGD (0.47) MEN1POLBAGTR1KMT2AALDH1A1
SCHEMBL13326533 0.67 ALDH1A1 (0.50) MEN1KMT2ACHRNB2CHRNA7CHRNA4
SCHEMBL1844542 0.66 ALDH1A1 (0.72) KMT2AALDH1A1NPC1HPGD
SCHEMBL27536629 0.65 CPN1 (0.53) GBA1CPN1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899324-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-19 EP claimed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO claimed
EP-1899324-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-19 EP disclosed
WO-2006127815-A2 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-11-30 WO disclosed